NDC 72934-5151

METRONIDAZOLE 1% / MUPIROCIN 2% /

Metronidazole 1% / Mupirocin 2% /

METRONIDAZOLE 1% / MUPIROCIN 2% / is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Mupirocin; Metronidazole.

• Product ID: 72934-5151_88de4a11-c76b-4405-e053-2995a90a4a29
• NDC: 72934-5151
• Product Type: Human Prescription Drug
• Proprietary Name: METRONIDAZOLE 1% / MUPIROCIN 2% /
• Generic Name: Metronidazole 1% / Mupirocin 2% /
• Dosage Form: Ointment
• Route of Administration: TOPICAL
• Marketing Start Date: 2019-05-14
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Sincerus Florida, LLC
• Substance Name: MUPIROCIN; METRONIDAZOLE
• Active Ingredient Strength: 2 g/100g; g/100g
• Pharm Classes: RNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA],Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72934-5151-2

30 g in 1 BOTTLE, PUMP (72934-5151-2)

• Marketing Start Date: 2019-05-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72934-5151-2 [72934515102]

METRONIDAZOLE 1% / MUPIROCIN 2% / OINTMENT

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-05-14

Drug Details

Active Ingredients

Ingredient	Strength
MUPIROCIN	2 g/100g

OpenFDA Data

• SPL SET ID: 88de4a11-c76a-4405-e053-2995a90a4a29
• Manufacturer:
  • Sincerus Florida, LLC
• UNII:
  • 140QMO216E
  • D0GX863OA5

Pharmacological Class

• RNA Synthetase Inhibitor Antibacterial [EPC]
• RNA Synthetase Inhibitors [MoA]
• Nitroimidazole Antimicrobial [EPC]
• Nitroimidazoles [CS]
• RNA Synthetase Inhibitor Antibacterial [EPC]
• RNA Synthetase Inhibitors [MoA]
• Nitroimidazole Antimicrobial [EPC]
• Nitroimidazoles [CS]